Published in Gut on November 01, 1976
Isolation and purification of human large bowel mucosal lymphoid cells: effect of separation technique on functional characteristics. Gut (1979) 1.88
T lymphocyte subsets in inflammatory bowel disease: peripheral blood. Gut (1983) 1.57
Alteration in T lymphocyte subpopulations in inflammatory bowel disease. Clin Exp Immunol (1980) 1.13
Preparation of lymphoid cells from small specimens of human gastrointestinal mucosa. Gut (1978) 1.02
Immune status in Crohn's disease. 2. Originally unimpaired primary cell mediated immunity in vitro. Gut (1978) 0.96
In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease: prevalence and relationship to disease activity immunoresponsiveness in IBD. Clin Exp Immunol (1979) 0.91
Relationship between trace elements, sugar consumption, and taste in Crohn's disease. Gut (1983) 0.88
Enumeration of lymphocyte populations defined by surface markers in the whole blood of patients with Crohn's disease. Gut (1982) 0.85
Peripheral blood and mesenteric lymph node lymphocytes in Crohn's disease. Gut (1980) 0.84
Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies. Gut (1978) 0.81
Loss of suppressor T-cells in active inflammatory bowel disease. Gut (1984) 0.80
Anergy in Crohn's disease. Br Med J (1977) 0.79
Influence of SRBC/lymphocyte ratio on T-cell rosettes in alcoholic liver disease and inflammatory bowel disease. Clin Exp Immunol (1977) 0.75
Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity. West J Med (1988) 0.75
Anergy in Crohn's disease--fact or fiction. Br Med J (1977) 0.75
Double-blind trial of the use of transfer factor in the treatment of Crohn's disease. Gut (1979) 0.75
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl (1968) 60.35
Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut (1960) 12.55
Human lymphocyte-sheep erythrocyte rosette formation: some characteristics of the interaction. Clin Immunol Immunopathol (1973) 3.55
The relation between regional ileitis and sarcoidosis. Lancet (1958) 3.29
Studies on delayed hypersensitivity in Hodgkin's disease. J Clin Invest (1962) 3.20
Delayed hypersensitivity and lymphocyte transformation in Crohn's disease and proctocolitis. Gut (1969) 2.61
Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med (1975) 2.59
Development of delayed hypersensitivity to dinitrochlorobenzene in patients with Crohn's disease. Gut (1969) 2.20
A study of Crohn's syndrome using tissue extracts and the Kveim and Mantoux tests. Gut (1965) 1.97
Peripheral blood T and B cells in chronic inflammatory bowel disease. Gastroenterology (1974) 1.97
Tuberculin sensitivity in Crohn's disease. A controlled study. Lancet (1967) 1.89
A method for dinitrochlorobenzene contact sensitization. A clinicopathological study. N Engl J Med (1972) 1.88
Impaired anamnestic cellular immune response in patients with Crohn's disease. Gut (1975) 1.65
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
No evidence for decreased lymphocyte reactivity in Crohn's disease. Gastroenterology (1974) 1.49
Delayed hypersensitivity in regional enteritis and ulcerative colitis. Am J Dig Dis (1966) 1.48
The immune competence of patients with inflammatory bowel disease. Gut (1974) 1.43
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Investigation of the pathogenic mechanisms in regional enteritis with in vitro lymphocyte cultures. Gastroenterology (1971) 1.40
Lymphocyte responses to nonspecific mitogens in inflammatory bowel disease. Gastroenterology (1973) 1.31
Inflammatory bowel disease: lymphocytic responses to nonspecific stimulation in vitro. Scand J Gastroenterol (1972) 1.26
Lymphocyte transformation in the mesenteric lymph nodes of patients with Crohn's disease. Gut (1973) 1.21
Lymphocyte transformation and delayed hypersensitivity in Crohn's disease. Scand J Gastroenterol (1972) 1.10
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07
Reactivity in vitro of lymphocytes from patients with ulcerative colitis. J Lab Clin Med (1967) 1.03
Letter: Lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1975) 0.91
Effect of E. coli antigens, tuberculin, and phytohaemagglutinin upon ulcerative colitis lymphocytes. Gut (1967) 0.88
Lymphoblastic response to autologous colon epithelial cells in ulcerative colitis in vitro. Gut (1973) 0.85
Letter: B lymphocytes in inflammatory bowel disease. Lancet (1974) 0.79
New observations in Crohn's disease. Annu Rev Med (1976) 0.78
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81
ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol (2001) 2.60
Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med (1975) 2.59
Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut (1988) 2.51
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol (1996) 2.42
The effect of localized injection of adjuvant material on the draining lymph node. II. Circulating lymphocytes. Immunology (1970) 2.19
Segregation of lymphocyte populations through differential migration. Nature (1969) 2.09
Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc Natl Acad Sci U S A (1997) 2.06
The effect of localized injection of adjuvant material on the draining lymph node. I. Histology. Immunology (1970) 2.00
Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96
PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol (1994) 1.91
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene (1995) 1.83
The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene (1995) 1.78
Immunologic dysfunction in heroin addicts. Arch Intern Med (1974) 1.77
How effective are current drugs for Crohn's disease? A meta-analysis. J Clin Gastroenterol (1992) 1.75
The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol (1996) 1.75
Management of Crohn's disease in adults. Am J Gastroenterol (1997) 1.65
Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61
Response of the normal and pathological human gastric mucosa to an instilled acid load. Gastroenterology (1968) 1.59
Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology (1985) 1.53
Cluster of inflammatory bowel disease in three close college friends? J Clin Gastroenterol (1993) 1.52
Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice. Immunology (1968) 1.52
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence. J Immunol (1972) 1.48
Patterns of neoplasia in Crohn's disease and ulcerative colitis. Cancer (1980) 1.45
Architectural organization in the interphase nucleus of the protozoan Trypanosoma brucei: location of telomeres and mini-chromosomes. EMBO J (1990) 1.44
Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg (1978) 1.44
Perpetuation of published medical errors. Lancet (1993) 1.43
Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology (1983) 1.43
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Granulomatous ileocolitis. Gut (1966) 1.42
The use of 6-mercaptopurine in adolescents. Gastroenterology (1991) 1.40
Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy. Cancer Res (1991) 1.40
Glucose therapy in short-bowel syndrome. Lancet (1971) 1.36
Extraintestinal cancers in inflammatory bowel disease. Cancer (1985) 1.34
Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. N Engl J Med (1972) 1.33
Cutaneous vasculitis complicating coeliac disease. Gut (1981) 1.27
Is there Kveim responsiveness in Crohn's disease? Lancet (1971) 1.26
Q fever in maritime Canada. Can Med Assoc J (1982) 1.25
Sex-linked retinitis pigmentosa: ultrastructure of photoreceptors and pigment epithelium. Invest Ophthalmol Vis Sci (1979) 1.23
Effects of lymphoid depletion on the distribution of 51Cr-labeled lymph node cells in mice. Transplantation (1971) 1.23
Trauma and the pyoderma gangrenosum of inflammatory bowel disease. Gut (1981) 1.22
Chronic portal-systemic encephalopathy after ileostomy and colonic resection. Lancet (1966) 1.22
Granulomatous diseases of the gastrointestinal tract. Annu Rev Med (1966) 1.20
Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology (1987) 1.19
Obstructive hydronephrosis. A frequent but seldom recognized complication of granulomatous disease of the bowel. N Engl J Med (1969) 1.18
Tumor-associated (CEA-reacting) antigen in patients with inflammatory bowel disease. N Engl J Med (1972) 1.18
Granulomatous colitis--pathogenetic concepts. Gastroenterology (1966) 1.17
Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology (1981) 1.16
Inhibition by diphenylhydantoin of folic acid absorption in man. Gastroenterology (1972) 1.16
Distribution of labeled lymph node cells in mice during the lymphocytosis induced by Bordetella pertussis. J Exp Med (1972) 1.14
Influence of glucagon on pancreatic exocrine secretion. Gastroenterology (1969) 1.12
Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance. Cancer Res (1987) 1.11
Systemic amyloidosis complicating inflammatory bowel disease. Gastroenterology (1997) 1.10
Secretion of calcium by the canine pancreas. Gastroenterology (1967) 1.10
Granulomas do not affect postoperative recurrence rates in Crohn's disease. Gastroenterology (1982) 1.10
Vitrectomy in eyes with peripheral retinal angioma associated with traction macular detachment. Ophthalmology (1996) 1.09
Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells. Cancer Res (1989) 1.09
Outcome of toxic dilatation in ulcerative and Crohn's colitis. J Clin Gastroenterol (1985) 1.07
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07
Chemotherapy for advanced sarcoma: therapeutic decisions and modalities. Semin Oncol (1997) 1.06
The amylase-creatinine clearance ratio. Diagnostic parameter or physiologic phenomenon? Am J Gastroenterol (1974) 1.06
Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q. Genomics (1992) 1.05
Mucosal blood flow in canine antral and fundic pouches. Gastroenterology (1971) 1.04
Lymphoma in inflammatory bowel disease. Cancer (1992) 1.03
Isolation and characterization of an anthracycline-resistant human leukemic cell line. Cancer Res (1985) 1.03
Effect of secretin and acetazolamide on the volume and electrolyte composition of hepatic bile in man. Gastroenterology (1969) 1.02
Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells. Cancer Res (1989) 1.02
Guide wire entrapment during PTCA: a potentially dangerous complication. Cathet Cardiovasc Diagn (1987) 1.02
Mitochondrial DNA sequencing of shed hairs and saliva on robbery caps: sensitivity and matching probabilities. J Forensic Sci (1998) 1.01
Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) (1992) 1.01
Fine-mapping and construction of a bovine contig spanning the ovine callipyge locus. Mamm Genome (2001) 1.01
ETO-2, a new member of the ETO-family of nuclear proteins. Oncogene (1999) 1.01
Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol (1987) 1.00
Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer. J Clin Oncol (1986) 1.00
Detection of tumorigenesis in rat bladders with optical coherence tomography. Med Phys (2001) 1.00
Collagenous gastritis associated with lymphocytic colitis. J Clin Gastroenterol (1996) 1.00
Quality of life after surgery for Crohn's disease: a psychosocial survey. Gastroenterology (1980) 0.99
Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Blood (1995) 0.98
A family with collagenous colitis, ulcerative colitis, and Crohn's disease. Am J Gastroenterol (2000) 0.98
Assessment of potential exposure to antineoplastic agents in the health care setting. Prev Med (1984) 0.97
Secretory capacity of stomach and pancreas in man. Gastroenterology (1967) 0.97
Enhancing early bladder cancer detection with fluorescence-guided endoscopic optical coherence tomography. Opt Lett (2003) 0.96
Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol (1994) 0.95
Treatment of ulcerative colitis with fish oil n--3-omega-fatty acid: an open trial. J Clin Gastroenterol (1990) 0.95
Intraabdominal abscess in Crohn's (ileo) colitis. Am J Surg (1982) 0.95
Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1. J Virol (2001) 0.94
Hematologic and immunologic aspects of parabiosis. Mt Sinai J Med (1976) 0.94